Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells

Cedric Moro, Jean Galitzky, Coralie Sengenes, François Crampes, Max Lafontan and Michel Berlan
Journal of Pharmacology and Experimental Therapeutics March 2004, 308 (3) 984-992; DOI: https://doi.org/10.1124/jpet.103.060913
Cedric Moro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Galitzky
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Coralie Sengenes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Crampes
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Max Lafontan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Berlan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 308 no. 3 984-992
DOI 
https://doi.org/10.1124/jpet.103.060913
PubMed 
14634036

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received October 3, 2003
  • Accepted November 17, 2003
  • Published online February 25, 2004.

Article Versions

  • Earlier version (November 21, 2003 - 13:44).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Cedric Moro,
  2. Jean Galitzky,
  3. Coralie Sengenes,
  4. François Crampes,
  5. Max Lafontan and
  6. Michel Berlan
  1. Unité de recherches sur les obésités, Institut National de la Santé et de la Recherche Médicale U586, Institut Louis Bugnard, Centre Hospitalier Universitaire Rangueil, Université Paul Sabatier, Toulouse, France (C.M., J.G., C.S., F.C., M.L., M.B.); Department for Adaptation to Exercise (F.C.), and Department of Clinical and Medical Pharmacology (M.B.) Purpan Hospital, Toulouse, France
  1. Address correspondence to:
    Dr. Max Lafontan, Unité INSERM 586, Institut Louis Bugnard, Hôpital Rangueil, 31403 Toulouse cedex 04, France. E-mail: Max.Lafontan{at}toulouse.inserm.fr
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: November 2003 to March 2023

AbstractFullPdf
Nov 2003607
Dec 200317044
Jan 200430043
Feb 2004611556
Mar 20041089960
Apr 2004234525
May 2004355737
Jun 2004708024
Jul 2004456119
Aug 2004395416
Sep 2004325322
Oct 200431329
Nov 2004184119
Dec 200423266
Jan 2005336826
Feb 2005182914
Mar 2005285732
Apr 2005113112
May 2005112419
Jun 200592619
Jul 200512246
Aug 200564415
Sep 2005134114
Oct 2005283920
Nov 2005153713
Dec 200513289
Jan 2006205711
Feb 2006242816
Mar 200664914
Apr 200681913
May 200691915
Jun 200671612
Jul 200672620
Aug 200651214
Sep 200652118
Oct 200653418
Nov 200685319
Dec 2006142320
Jan 20078148
Feb 20076217
Mar 20077148
Apr 2007141914
May 200741211
Jun 200791113
Jul 2007112822
Aug 20076183
Sep 200762212
Oct 200781713
Nov 2007141815
Dec 20076157
Jan 20088178
Feb 200871410
Mar 200815149
Apr 200852425
May 2008113920
Jun 2008221111
Jul 2008271311
Aug 200815308
Sep 20088206
Oct 200810119
Nov 200818187
Dec 200811127
Jan 2009899
Feb 2009111618
Mar 2009311410
Apr 2009863
May 20099611
Jun 2009956
Jul 20098717
Aug 2009597
Sep 20091395
Oct 2009301212
Nov 20092357
Dec 20092616
Jan 2010101110
Feb 201091013
Mar 2010895
Apr 201017138
May 2010975
Jun 20106106
Jul 20107118
Aug 20101066
Sep 201012105
Oct 20105119
Nov 20101559
Dec 2010963
Jan 20116136
Feb 2011102311
Mar 2011131312
Apr 2011181111
May 2011171014
Jun 2011101113
Jul 20111935
Aug 20111859
Sep 201118179
Oct 201116206
Nov 2011201416
Dec 2011131414
Jan 2012241216
Feb 201214617
Mar 2012161412
Apr 2012171913
May 201215129
Jun 201223117
Jul 2012211614
Aug 20121479
Sep 20121167
Oct 2012111217
Nov 2012161836
Dec 201212125
Jan 2013181212
Feb 201311133
Mar 201313109
Apr 2013121720
May 2013271526
Jun 20139726
Jul 201310413
Aug 201316917
Sep 2013181210
Oct 20136146
Nov 2013787
Dec 201310116
Jan 201414101
Feb 20148123
Mar 201415167
Apr 201461166
May 201439154
Jun 201418125
Jul 201417147
Aug 201410145
Sep 201492212
Oct 20141784
Nov 2014854
Dec 2014101110
Jan 20158113
Feb 20151154
Mar 201513134
Apr 2015541
May 20151174
Jun 20159112
Jul 201551310
Aug 201514106
Sep 201556212
Oct 20151211296
Nov 20152215256
Dec 2015225243
Jan 20163313224
Feb 20161212225
Mar 201615855
Apr 2016111197
May 20166561
Jun 20169950
Jul 20163827
Aug 2016121035
Sep 2016171118
Oct 2016113227
Nov 2016211182
Dec 2016010248
Jan 2017020214
Feb 2017217242
Mar 2017117291
Apr 2017114276
May 2017036283
Jun 2017016235
Jul 2017129232
Aug 20172119244
Sep 2017219272
Oct 2017020222
Nov 2017732219
Dec 2017329220
Jan 2018325239
Feb 2018134267
Mar 2018028342
Apr 2018128320
May 2018036376
Jun 2018134355
Jul 2018321394
Aug 2018035400
Sep 2018125385
Oct 2018618370
Nov 2018029290
Dec 2018228758
Jan 201937623
Feb 201931582
Mar 201931111
Apr 201925900
May 201925632
Jun 201928215
Jul 2019309130
Aug 201921422
Sep 201924733
Oct 201919510
Nov 201926320
Dec 201926524
Jan 202032363
Feb 202031810
Mar 202022000
Apr 202017700
May 202021420
Jun 202015800
Jul 202015222
Aug 202013412
Sep 202018323
Oct 202011211
Nov 202018822
Dec 202019711
Jan 202113961
Feb 20216522
Mar 20213322
Apr 20211041
May 20211973
Jun 20212243
Jul 20211835
Aug 20211525
Sep 20211954
Oct 20212932
Nov 20211920
Dec 20212600
Jan 20221838
Feb 20221232
Mar 20221742
Apr 20222625
May 20223036
Jun 20222832
Jul 20223821
Aug 20223221
Sep 20221924
Oct 20223610
Nov 20222121
Dec 20221822
Jan 20232423
Feb 20231310
Mar 20234324

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 308 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 308, Issue 3
1 Mar 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells

Cedric Moro, Jean Galitzky, Coralie Sengenes, François Crampes, Max Lafontan and Michel Berlan
Journal of Pharmacology and Experimental Therapeutics March 1, 2004, 308 (3) 984-992; DOI: https://doi.org/10.1124/jpet.103.060913

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Functional and Pharmacological Characterization of the Natriuretic Peptide-Dependent Lipolytic Pathway in Human Fat Cells

Cedric Moro, Jean Galitzky, Coralie Sengenes, François Crampes, Max Lafontan and Michel Berlan
Journal of Pharmacology and Experimental Therapeutics March 1, 2004, 308 (3) 984-992; DOI: https://doi.org/10.1124/jpet.103.060913
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Transport Is Not Rate-Limiting in Morphine Glucuronidation in the Single-Pass Perfused Rat Liver Preparation
  • Enhanced Hepatic Uptake and Bioactivity of Type α1(I) Collagen Gene Promoter-Specific Triplex-Forming Oligonucleotides after Conjugation with Cholesterol
  • Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana
Show more ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics